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Abstract: Human papillomavirus (HPV) is a DNA virus that presents tropism for epithelial cells, causing
infections of the skin and mucous membranes. Replication of HPV occurs in the nuclei of squamous
cells and its life cycle is directly related to the differentiation program of the host cell. To date, nearly
100 different types of HPV have been characterized and there is a large number of other types that have
not been sequenced yet. Besides being responsible for benign lesions of the skin and mucous mem-
branes, HPV is also involved in the development of various mucocutaneous tumors: Bowen's disease,
non-melanoma skin cancers and genital carcinomas. This review discusses the characteristics of HPV,
malignant and benign mucous and skin manifestations caused by HPV, besides the main methods of
detection and typing of the virus.
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Resumo: O papilomavírus humano (HPV) é um vírus DNA que apresenta tropismo por células
epiteliais, causando infecções na pele e nas mucosas. A replicação do HPV ocorre no núcleo das células
escamosas e o seu ciclo de vida é diretamente relacionado ao programa de diferenciação da célula hos-
pedeira. Até o momento, foram completamente caracterizados cerca de 100 tipos diferentes de HPVs e
há um grande número adicional de tipos ainda não sequenciados. Além de ser o responsável por lesões
benignas de pele e mucosas, o HPV também está envolvido no desenvolvimento de diversos tumores
cutaneomucosos: doença de Bowen, cânceres de pele não melanoma e carcinomas genitais. Esta revisão
aborda as características do HPV, quadros cutâneos e mucosos benignos e malignos causados por ele e
os principais métodos empregados em sua detecção e tipagem.
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INTRODUCTION
Papillomatous and verrucous lesions affecting
the skin have been described since ancient Greece.
Research on papillomavirus (PV) began in the early
twentieth century. In 1933, a PV was isolated as a pos-
sible etiologic agent of warts in rabbits. Since then,
this class of viruses has been considered natural viral
infectious agents responsible for the development of
warts in different groups of mammals, including man.
In 1935, Rous described the warts in rabbits as
having the potential for malignant transformation.
Strauss et al. reported the first visualization of PV par-
ticles in human warts by means of electron
microscopy in 1949. In 1950, the carcinogenic poten-
tial of the human papillomavirus (HPV) was discov-
ered in patients with epidermodysplasia verruci-
formis. The structure of the viral genome was only
unveiled in 1963 by Crawford & Crawford.1 However,
in the subsequent years, research on HPV was discour-
aged due to the lack of a system of tissue culture and
to the apparently benign nature of human warts.
In the 1970s, a gradual interest in these viruses
started to arise. At that time, investigators described
the diversity of this class of viruses, and Zur Hausen
proposed the hypothesis that HPVs participated in the
etiology of cervical cancers. 2
In the early 1980s, there was a rapid increase in
research on HPV; consequently, HPVs 16 and 18 were
identified and their relationship with cervical cancer
was established. The first epidemiological study on
HPV and cervical cancer was published in 1987. 3
Since then, several epidemiological and molecular
studies have confirmed that cervical infection by cer-
tain HPV types is a precursor of the genesis of cervical
neoplasia.
CHARACTERISTICS OF THE VIRUSES
PVs are small DNA viruses (50-55 nm) belong-
ing to the family Papovaviridae - genus Papillomavirus.
They are non-enveloped viruses with icosahedral sym-
metry and present a genome of about 8000 base pairs
(8Kb) of double-stranded, circular DNA. Despite their
small size, the molecular biology of these viruses is
quite complex. The viral DNA is associated with pro-
teins similar to histones, wrapped in 72 capsomeres
composed of two structural proteins, L1 and L2.
These viruses can infect humans and a large number
of animal species (cats, rabbits and nonhuman pri-
mates); man is the most extensively studied host 4.
PVs are highly species-specific and there is no
report of a PV species causing productive infection in
another species. They are viruses that exhibit tropism
for epithelial cells causing infections of the skin and
mucous membranes (genitals, mouth, larynx, esopha-
gus), and their replication occurs in the nucleus of
squamous epithelial cells. 5
Their viral genome is divided into three regions
based on their location and functional properties. The
E (early) and L (late) regions, known as ORFs (Open
Reading Frames or translation units), and a third
region called LCR (long control region) or NCR (non-
coding region) or URR (upstream regulatory region).
The E region contains up to eight genes (E1 to
E8), which are responsible for replication of the HPV
(E1 and E2), DNA transcription (E2), maturation and
release of viral particles (E4), cell transformation (E5,
E6, E7), and immortalization (E6 and E7). The E6/E7
genes also encode proteins associated with malignant
lesions.6 These proteins stimulate cell proliferation by
interacting and suppressing the functions of cellular
proteins p53 and pRb, involved in controlling cell pro-
liferation. Only the E6/E7 proteins of high-risk HPVs
are able to immortalize primary human keratinocytes,
but not similar proteins of low-risk HPVs.
The genes of the L region (L1 and L2) encode a
major and a minor capsid protein, respectively.7 The
late region L1 ORF is the most conserved among the
HPVs. Its product, the L1 protein, represents 80% of
the viral capsid proteins, being the most abundant
protein and highly immunogenic. The L2 protein,
together with the L1, contributes to the incorporation
of the viral DNA into the virion. 
The LCR region is between L1 and E6 and has
between 500 and 1000 base pairs. In general, it is not
well conserved among the HPVs and is involved in the
gene expression and viral replication that occurs in
the nucleus of the host cell.
Consistent evidence suggests that the genome
of PVs is static and changes in their sequence by muta-
tion or recombination are very rare events. Mutational
changes seem to occur at a frequency similar to that
occurring in the genome of the infected host. 4
The life cycle of a PV is directly related to the
cellular differentiation program of the host cell. The
virus infects the epithelial basal cells that have the
potential for differentiation. Vegetative viral functions,
synthesis of DNA and capsid proteins, as well as
assembly of new viruses occur exclusively in differen-
tiated keratinocytes. 8
PVs appear to remain in their host for long peri-
ods of life. A variety of different types of PVs can be
detected in random sites of normal skin in humans
and animals. This reinforces that a latent life cycle is
often a characteristic of these viruses. 9
PHYLOGENETICS
Unlike other viral groups, PVs are not men-
tioned by serotypes. Classification of these viruses is
based on the species of origin and the degree of rela-
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tionship between viral genomes.8 They are classified
into different types by comparing the nucleotide
sequence of their viral genome.
PVs are grouped into different genera, which in
turn are divided into different species containing one
or more genotypes. Each genotype is grouped into
subtypes and variants depending on the similarity of
the sequence in the L1 region. 4
To date, about 100 different types of HPVs
have been fully characterized. 4 In addition to all of
these HPVs that have been fully sequenced, there is
a large number of additional types whose genetic
sequence has not been obtained through conven-
tional methods yet.8
Different genera of HPVs share less than 60%
similarity in the nucleotide sequence of the major
capsid of the protein L1 ORF. Different virus species
within the same genus share about 60% to 70% simi-
larity. It is considered a new HPV type when its
genome shows variations greater than 10% in L1, E6
and E7 genes, and when compared with any previous-
ly known type of HPV. Differences between 2 and 10%
represent new subtypes and variations under 2% are
variants of types. 4
HPVs are grouped into the following genera:
Alpha-, Beta-, Gamma-, Mu- and Nu-papillomavirus.
The other genera include PVs isolated in mammals
and birds. The phylogenetic grouping sometimes
reflects biological and pathological similarities, but
often there are differences. For example, various
types and species of the same genus can display com-
pletely different characteristics and still belong to the
same genus. 4.8
Alpha-papillomavirus (Supergroup A)
Those HPVs with tropism for genital epithelium
are part of this group. However, some types belong-
ing to this genus cause common warts. This genus
includes the types of HPV that present high risk for
cervical cancer such as HPVs 16 and 18, respectively
allocated in species 9 and 7 of this genus, as well as
low-risk types of HPV such as HPVs 6 and 11, both in
species 10. At the same time, this same genus includes
non-mucosal HPV types, such as HPV 7 - associated
with cutaneous warts in butchers and handlers of
meat, poultry and fish, HPVs found in species 4 (HPVs
2, 27 and 57), and those found in species 2 (HPVs 3
and 10), which cause common warts on the skin. 4,8,10 
Beta-papillomavirus (Supergroup B - Subgroup B1)
They are divided into five different species.
HPVs 5 and 8, which belong to species 1 of this genus,
are the most commonly identified in the skin of indi-
viduals with epidermodysplasia verruciformis (EV).
This genus also involves cutaneous HPVs detected in
the skin of the population in general without skin
lesions, demonstrating the ubiquity and high inci-
dence of asymptomatic infections. 4,5,8,10
Gamma-papillomavirus (Supergroup B - Subgroup B2)
It covers five different species with seven differ-
ent types that cause skin lesions: HPVs 4, 48, 50, 60,
88, 65, and 95. 4,5,8
Mu-papillomavirus (Supergroup E)
It includes HPVs 1 and 63. HPV 1 is the most
studied member of this group and causes common
and palmar warts. 4,5,8
Nu-papillomavirus (Supergroup E)
It has only one species: HPV 41. 4,5,8
CLASSIFICATION
Historically, HPVs are grouped considering
their tissue tropism for certain types of epithelium
and according to the location where they were first
isolated. Based on these characteristics, there are
three main groups of HPV: cutaneous, mucosal, and
associated with EV (Table 1). Mucosal HPVs are divid-
ed into low and high risk according to their oncogenic
potential.
All types of HPV have tropism for cells of the
stratified squamous epithelium, but there are varia-
tions in terms of affinity for different anatomical sites.
For example, HPV-1 is a skin type with a high rate of
replication in keratinized epithelium of the palmar
and plantar regions. HPV 16 is a mucosal HPV type
with preference for genital areas, and HPV 11, also
mucosal, presents replication in laryngeal and genital
epithelium. 11
This classification is not entirely correct,
because genital HPV types can be detected in the skin
and the opposite is also possible. 
TECHNIQUES FOR DETECTION OF HPV
HPV does not grow on conventional culture
media and serological diagnostic methods have limit-
ed accuracy. The diagnosis of HPV infection is made by
histopathology of  lesions11 or detection of viral DNA
in infected cells.12
Hybridization techniques and polymerase chain
reaction (PCR) are methods used for HPV detection.
Among the hybridization techniques used are
the following:
1) Southern blot has high specificity and sensi-
tivity. It allows estimates of the amount of DNA in the
lesion. It has limitations due to the high diversity of
types of HPV, since it does not detect the DNA of
unknown viral sequences. 13
2) Dot blot and reverse blot are laborious tech-
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niques that present similar sensitivity and good accu-
racy. 12.13
3) In situ hybridization uses radiolabeled
probes and allows for topographic localization of viral
DNA in cells and tissues. Although the sensitivity of
this technique is limited, it is the best method to
assess the distribution of HPV in lesions and it allows
for viral localization by means of other markers. 13
4) Non-radioactive hybrid capture: this tech-
nique is safe, easy to perform and reproduce. It pres-
ents good accuracy for mucosal lesions. 13
Polymerase chain reaction (PCR) is the most
sensitive method. It is also the most widely used for
viral detection and its main application is related to
situations where the amount of DNA available is limit-
ed. First, it is necessary to extract the genetic material
to be used. After extracting the DNA, a mixture (pre-
mix) containing deoxyribonucleotide triphosphates
(dATP, dCPT, dGTP, dTTP), primers (oligonucleotides),
the DNA polymerase enzyme, and a buffer solution is
added. This whole mix is sent to the thermal cycler,
which runs in pre-defined temperature cycles, with
specific time periods for each step of the reaction
(denaturation, annealing, extension). The PCR result
is visualized as a band of molecular weight specific for
the DNA fragment amplified by electrophoresis on
polyacrylamide or agarose gel, using staining with
ethidium bromide. 
After amplification of viral DNA by PCR, the
material needs to be subjected to a technique that per-
mits identification of the HPV type. The techniques
most often used for typing of the DNA amplified by
means of PCR are: Southern blot, dot blot, reverse
hybridization, restriction enzyme digestion, and
sequencing. 12
CLINICAL MANIFESTATIONS OF HPV INFECTION
I. Benign cutaneous lesions
CUTANEOUS WARTS
Warts are the most common and characteristic
clinical manifestations of HPV infection. They are
virus-induced pleomorphic tumors which affect vari-
ous sites, particularly the skin of the extremities,
mucosa, genital skin, and laryngeal and oral mucosas. 11
Epidemiology, transmission and pathogenesis
HPV is a virus with worldwide distribution. Viral
warts are very common viral infections, with an esti-
mated incidence of 7 to 10% in the European popula-
tion and 1% in the U.S. population.14 These numbers
increase 50 to 100 times in immunocompromised
individuals; for example, in kidney-transplant recipi-
ents, reaching more than 90% 15 years after transplan-
tation.15 Warts occur at any age and incidence increas-
es during the school age, with a peak in adolescence
and early adulthood. 16
HPV is transmitted through direct or indirect
contact with an individual who has the lesion.
Dysfunctions in the epithelial barrier by trauma,
minor injuries or maceration cause loss of solution of
continuity in the skin, thus allowing viral infection.
After inoculation, the incubation period varies from 3
weeks to 8 months. 39 Spontaneous regression is
observed in most cases. 17
Cell-mediated immunity (CMI) seems to have a
TABLE 1: Classification of HPV types into cutaneous, mucosal (genital), cutaneous and / or mucosal and cuta-
neous associated with epidermodysplasia verruciformis according to the location of the lesion that it most
often causes 
Location HPV types
Cutaneous 1, 4, 41, 48, 60, 63, 65, 76, 77, 88, 95
Mucosal 6, 11, 13, 16, 18, 26, 30, 31, 32, 33, 34, 35, 39, 42, 44, 45, 
51, 52, 53, 54, 55, 56, 58, 59, 64, 66, 67, 68, 69, 70, 72, 73, 
74, 81, 82, 83, 84, 86, 87, 89
Cutaneous and/or mucosal 2, 3, 7, 10, 27, 28, 29, 40, 43, 57, 61, 62, 78, 91, 
94, 101, 103
Cutaneous associated  5, 8, 9, 12, 14, 15, 17, 19, 20/46*, 21, 22, 23, 24, 25, 36, 37,
with Epidermodysplasia Verruciformis 38, 47, 49, 50, 80, 75, 92, 93, 96, 107
* HPV 46 is a subtype of HPV 20
DE VILLIERS modified TABLE, 2004
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more important role in the host response to HPV. A
higher prevalence of warts and longer and persistent
manifestations are observed in patients with CMI sup-
pression, such as in kidney-transplant recipients, indi-
viduals with HIV (human immunodeficiency virus),
and patients with EV. 5,11,17
The life cycle of an HPV is directly linked to the
cell differentiation program of the host cell. Infection
begins when the HPV reaches the cells of the basal
layer; there is no viral replication at this location and
the virus just keeps its genome by amplification of a
low number of copies. The replicative phase and pro-
tein synthesis occur in the suprabasal differentiated
keratinocytes. 5.18 Progression time and type of lesion
correlates with the quantity of viral particles detected.
Younger warts present a higher viral amount when
compared to old warts. Plantar warts have a higher
viral load than common warts. The center of the
lesion appears to be the main site of viral concentra-
tion. 18
In benign lesions, replication of the viral
genome is extracromossomal. In malignant lesions,
the viral DNA is integrated into the chromosomes of
the host cell and there is no viral replication. There is
inactivation of expression of the E2 protein, which
acts as a negative regulator of the expression of the E6
and E7 oncogenes. The last two promote cell immor-
talization by inhibiting cellular proteins that regulate
the cell cycle (p53 and pRB), which are critical for
tumor suppression. 5.18
Histopathological characteristics of cutaneous warts
The histopathological characteristics of viral
warts are papillomatosis, hyperkeratosis with promi-
nent parakeratosis, hypergranulosis and acanthosis. 19
The rete ridges of common warts are elongated
and at the periphery point radially toward the center
of the lesion (arborization). The most important char-
acteristics in distinguishing common warts from other
papillomas are: a) koilocytes (small vacuolated cells
with small round strongly basophilic nucleus sur-
rounded by a clear halo and pale cytoplasm, located
in the outer stratum spinosum and stratum granulo-
sum); they represent the viral cytopathic effect, b) ver-
tical rows of parakeratosis, and c) foci of keratohyalin
granules. These three changes are evident in young or
active common warts. 19
Some authors have suggested that certain histo-
logical features are specific to each type of HPV. Thus,
histopathological examination would help in identify-
ing different viral types. Other researchers do not
agree that different HPVs determine different histolog-
ic patterns that are characteristic of each virus type;
therefore, there would be no correlation between his-
tology and HPV type. 17
Flat warts show hyperkeratosis and acanthosis.
Papillomatosis and areas of parakeratosis are not less
prominent, with only a slight elongation of rete ridges
being observed. There is diffuse vacuolation and
increase in cell size with centralization of nuclei that
become strongly basophilic and pyknotic in the spin-
ous and granular layers. Superficial palmoplantar
warts (mosaic) present histopathological aspects simi-
lar to common warts. As for deep palmoplantar warts
(myrmecia), they are characterized by presenting, in
the granular and spinous layers, abundant kerato-
hyalin granules and eosinophils forming irregular
inclusion bodies in the cytoplasm of keratinocytes. 17.19
I. 1. COMMON WARTS
They are individualized papules or nodules
with a rough surface. Lesions may be single or multi-
ple, of varying sizes and are usually asymptomatic
(Figure 1). Confluence of lesions can form large mass-
es. They occur in any part of the integument, but are
more common on the back of hands and fingers. 17 A
frequent location in children is the knee. 11
Isolated warts may remain unaltered for
months or years, or a large number of new lesions
may develop rapidly in a short period of time. The
development of warts is not predictable.
Approximately 65% of warts disappear spontaneously
within two years. The patient’s age and number of
lesions do not seem to affect the prognosis. 20
The types of HPV most involved in lesions of
common warts or verruca vulgaris (VV) are: HPV 25.21,
HPV 27, HPV 57 21.22 (HPV types closely related to HPV
2), HPV 4 5.23 and HPV 1. 24.25 HPV 7 is the most frequent
type of warts in butchers and is also described in fish
and poultry handlers. 26
FIGURE 1: Common wart on the back of the third right finger
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I. 2. PLANTAR WART
Warts that occur on the plantar region. They
may lie deep, and this presentation form is known as
myrmecia. They are commonly painful and caused by
HPV 1. When developed more superficially, forming
hyperkeratotic plaques, they are called mosaic warts,
which are less painful and usually caused by HPV 2.
HPV 4 is also detected in lesions of plantar warts. 27
I. 3. FLAT WARTS
Flat warts are slightly raised, of skin color or
pigmented (brownish, slightly yellowish), with flat,
smooth or slightly rough surface. They are rounded or
polygonal and their size ranges from 1 to 5 mm in
diameter or more (Figure 2). The face and back of
hands are the most common locations. The warts may
be numerous and there is often linear distribution of
lesions corresponding to excoriated lesion or other
trauma (Koebner phenomenon). Spontaneous regres-
sion is common, usually preceded by inflammation of
the lesions. The HPV types most frequently detected
in lesions of flat warts are HPV 3 and HPV 10. 11.17
I.4. FILIFORM WARTS
These are pedunculated, spiculated lesions
growing in a perpendicular or oblique way in relation
to the skin surface (Figure 3). They appear as isolated
or multiple lesions affecting mainly the face and neck.
It is a morphological variation of the common wart
and the HPV types found appear to be the same found
in lesions of common warts, especially HPV 2. 11
I.5. PIGMENTED WARTS
Clinically, pigmented warts present coloration
varying from gray to blackish-brown, and histopatho-
logically, they present specific homogeneous cytoplas-
mic inclusion bodies (Figure 4). The HPV types detect-
ed in these lesions are HPV 4, 60 and 65. 28
II. EPIDERMODYSPLASIA VERRUCIFORMIS (EV)
It is a rare, usually autosomal recessive, genetic
disorder where there is cellular immunity defect and
high susceptibility to skin cancer induced by HPV. The
association between HPV and cancer was first recog-
nized in the 50s among patients with EV. Patients with
EV are highly predisposed to infection by a specific
group of HPVs and at a high risk of developing cuta-
neous malignant tumors, resulting from the onco-
genic effects of the viruses. 29
The skin lesions appear early in childhood and
are polymorphic. They are indistinguishable from flat
warts when present on the face and neck, and scaly
hypo or hyper-pigmented erythematous macules, sim-
ilar to versicolor, when present on the trunk and
limbs. Thicker, pink or violet plaques, similar to seb-
orrheic keratosis, are also found. Malignant transfor-
mations generally begin in the fourth and fifth
decades of life and predominate in sun-exposed areas,
suggesting an important role of ultraviolet radiation.
Premalignant lesions such as actinic keratoses and
malignant lesions such as Bowen’s disease and inva-
sive squamous cell carcinoma are observed. Basal cell
carcinoma is rare in these patients. 30
The HPV types found in lesions of patients with
EV are referred to as HPVs associated with epider-
modysplasia verruciformis (HPV-EV). The HPV-EV
types most commonly found in lesions of patients
with EV are 5, 8, 9, 12, 14, 15, 17, 19-25, 28, 29, 36-
38, 47, 49 and 50. HPV 3 and 10 are detected in the
flat warts of these patients, similar to the general pop-
ulation. HPV 5, followed by HPV 8, is the most com-
monly found in malignant lesions. HPV 14, 17, 20 and
47 are less frequently found. 13,30,31
With the advancement of techniques for HPV
identification and typing, HPV-EVs began to be detect-
ed not only in patients with the diagnosis of EV but
also in normal skin and lesions of and immunocom-
FIGURE 2: Flat wart on the ankle FIGURE 3: Filiform wart in kidney-transplant recipient
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promised (Figure 5) and immunocompetent individu-
als - not commonly pathogenic in the latter, in
patients with psoriasis and in patients with a disorder
of keratinocyte proliferation such as autoimmune bul-
lous diseases and burns. 4,9,32,33
III. MALIGNANT SKIN LESIONS
III.1. BOWEN’S DISEASE
Bowen’s disease (BD) is a squamous cell carci-
noma in situ that occasionally progresses to invasive
carcinoma.
According to the literature, HPV, particularly the
high-risk mucosal types,  are frequently found in
lesions of extra-genital Bowen’s disease (EGBD),
especially in the periungual region, on hands and
more rarely on feet. The detection of the virus in these
locations suggests autoinoculation from genital
lesions. 34
The role of HPV is well established in genital
BD, but is not fully clarified in its extra-genital forms. 35
In EGBD, HPV detection is not restricted to the
extremities (feet, hands, periungual region). High-risk
HPVs are also found in lesions of EGBD in the absence
of genital lesions. 35
Other types of HPV have been detected in
EGBD, such as HPV 2, low-risk mucosal HPVs 6 and
11, HPV 54, 58, 61, 62, 73, HPV 58 detected in EGBD
located on elbows, fingers and toes associated with
cervical and vulvar carcinoma, cutaneous HPVs such
as HPV 27, HPV 76 and HPV-EV 20 and HP-EV 23.
In 2005, Zheng et al. 35 evaluated samples from
41 patients with EGBD and detected high-risk mucos-
al HPVs in 7% of the lesions (HPV 16 and 33) and cuta-
neous HPVs (HPV 27 and 76) in 5% of them. In lesions
with high-risk HPV, the viral load was high and demon-
stration of viral DNA in the nucleus of cells of the spin-
ous layer and part of the basal layer in the tissue affect-
ed by EGBD was easily detectable by the in situ
hybridization technique. These findings were not
observed in lesions of cutaneous HPV types and in
control samples of normal skin. Based on these
results, the authors concluded that high-risk mucosal
HPVs may play an important role in the pathogenesis
of EGDB. 
III.2.BASAL AND SQUAMOUS CELL CARCINOMAS
The exact role of HPV in the development of
nonmelanoma skin cancer (NMSC) - squamous cell
carcinoma (SCC) and basal cell carcinoma (BCC) - is
not yet fully defined.36 Growing evidence suggests that
HPV has important potential in the process of skin car-
cinogenesis. 36,37,38
The association between HPV and NMSC is
observed both in immunocompetent patients and
immunocompromised individuals. In the latter, posi-
tive detection of viral DNA in lesions is higher and
presence of varied types of HPV in the same lesion is
more frequent. 13,37,39 More than 90% of kidney-trans-
plant recipients who had a transplant over 15 years
ago will develop viral warts; and 40% will develop
NMSC, that is, a risk of 50 to 100 times higher than the
general population. In this group of patients, unlike
what is observed in the general population, the most
prevalent type of NMSC is the SCC, in an approximate
ratio of 3:1, and lesions tend to be multiple and more
aggressive. 15 In lesions of SCC of kidney-transplant
recipients, HPV-EVs are the most commonly found.
Detection of HPV in these lesions is high, reaching up
to 80-88%. 32.37 Detection of new types of HPV-EV is
common, as well as coinfection of the same lesion
with more than one HPV type. In lesions of BCC, HPV
detection is lower. 32,37,39
There are few studies on HPV and NMSC
lesions in immunocompetent individuals. In these
individuals, HPV prevalence is lower, ranging from
35% to 55% in lesions of SCC and 43.5% in BCC. 37.39
FIGURE 4: Pigmented wart FIGURE 5: Flat warts in epidermodysplasia verruciformis-simile in a
kidney-transplant recipient
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HPV-EVs are also the predominant types. Skin and
mucosal types have also been detected; however, it
can be observed in studies that show these types as
the most common that the methods for detection of
EV types are limited and unsatisfactory. 37.39
In 2000, Harwood et al. 39 detected the pres-
ence of HPV in 84.1% of SCC lesions and in 75% of
BCC lesions of immunocompromised patients who
had undergone kidney transplantation, compared to
27.2% of SCC lesions and 36.7% of BCC lesions in the
immunocompetent group. The prevalent HPV type in
both groups was HPV-EV. Cutaneous types of HPV and
infection by multiple HPV types were observed only in
the group of immunocompromised. There were no
statistically significant differences between BCC and
SCC with respect to the HPV types present in the
lesions.
In 2003, Iftner et al.,24 conducted a case-control
study to investigate the association between HPV and
NMSC. HPV was detected in 59.7% of the 72 SCC sam-
ples analyzed and in 27.8% of the 18 BCC lesions. HPV
4 and HPV 33 were the most prevalent in the lesions
of NMSC. The authors noted that high-risk mucosal
HPVs may represent a risk factor for NMSC lesions in
immunocompetent patients.
Forslund et al. , in 2007, 38 studied 349
immunocompetent patients with skin lesions: 82
lesions of SCC, 126 lesions of BCC, 49 lesions of
actinic keratosis and 92 benign lesions (only one case
of common wart). Paired biopsies of normal skin from
the same patient were carried out, they were also sub-
mitted to PCR for detection of HPV DNA. 42 different
types of HPV were identified and there was a strong
association between HPV prevalence and solar expo-
sure. HPVs from the beta-papillomavirus group,
species 1 were more frequent in benign lesions,
whereas HPV types of the genus beta-papillomavirus,
species 2 predominated in lesions of SCC. The
authors conclude that the HPV types of the genus
beta-papillomavirus, species 2 are implicated in the
etiology of skin SCC.
In 2008, Asgari et al. 36 conducted a case-control
study in Caucasian immunocompetent individuals in
order to analyze the role of HPV in skin lesions of
NMSC. 132 patients with SCC and 95 individuals with-
out lesions of NMSC were analyzed. Material from the
lesion and the perilesional area were obtained from
patients with NMSC lesions. In the control group, the
material was obtained from exposed area and areas
not exposed to sunlight. HPV prevalence was similar
in both study groups, suggesting that HPV is widely
distributed in the general population. When com-
pared to the control group, HPV types of the genus
beta-papillomavirus (HPV-EV) species 2 were more
prevalent in lesions of NMSC, suggesting that certain
types of HPV may be involved in the progression of
NMSC; however, additional factors for cancer develop-
ment would be necessary.
Detection and typing of HPV in NMSC lesions
are hampered by the genomic variety of these viruses.
Moreover, the techniques used by the early 1990s
were less capable of meeting this viral complexity.
Despite considerable progress in methods of detec-
tion and typing, the introduction of new primers and
use of degenerate primers, discrepancies in the preva-
lence and spectrum of viral types found in these
lesions in different studies are still observed.37,39
Detection of mucosal HPVs in lesions of SCC is fre-
quent, and the most commonly identified is HPV 16. 40
The possible association of genital carcinomas and
ungual SCC was documented in several studies, sug-
gesting autoinoculation from genital lesions. 38 More
rarely, other types of HPV are also found in lesions of
ungual SCC, such as HPV 2, 31, 34, 35, 58, 61 and 73. 38.40
IV. BENIGN MUCOSAL LESIONS 
IV.1. FOCAL EPITHELIAL HYPERPLASIA
Focal epithelial hyperplasia (FEH) or Heck’s
disease is a rare disease of the oral mucosa. It has a
benign course and is associated with HPV 13 and 32.
41 It is more common in children and women and
presents clear racial predominance, being more com-
mon among American Indians, Eskimos and some
African communities. It is clinically characterized by
multiple small papules, pinkish in color, individual or
forming plaques (Figure 6). Its lesions are asympto-
matic and prone to spontaneous regression. The most
common location is the lower lip. Less frequently,
FEH affects the upper lip, tongue, oral mucosa,
oropharynx, palate and floor of mouth.
IV.2. CONDYLOMATA ACUMINATA
The most common manifestations of HPV in the
genital area are anogenital warts or condylomata
acuminata.13 These lesions present as papules, nod-
ules or soft, filiform, pinkish, sessile or pedunculated
growths. They may present exophytic growth similar
to a cauliflower and are usually asymptomatic. The
low-risk HPVs, HPV 6 and HPV 11, are the most detect-
ed ones in lesions of condylomata acuminata. High-
risk HPVs such as HPV 16 and 18 and other HPV types
can be found isolated or more often coinfected with
HPV 6 and 11. 42
The Buschke-Loewenstein tumor (giant condy-
loma acuminatum or verrucous carcinoma of the
anogenital region) is a clinically aggressive tumor,
with ulcerated cauliflower-like lesions, often associat-
ed with fistulas and abscesses. They present exophyt-
ic and endophytic growth, local invasion and high
recurrence rates. Metastases are very rare, and histo-
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logically, it is benign. This lesion is associated with
HPV 6 and 11. 43
IV.3. BOWENOID PAPULOSIS
The term bowenoid papulosis (BP) refers to
multifocal papular lesions on the genitalia with his-
tological features similar to SCC in situ or BD. Its
clinical manifestation is characterized by multiple
brownish or erythematous papules located in the
anogenital region, affecting mostly young adults
with an active sex life. Clinically, it must be differ-
entiated from seborrheic keratosis, melanocytic
nevus and common warts. BP is strongly associated
with HPV 16. 13
Despite the histological atypia and associa-
tion with high-risk HPV, the course of BP in males and
in young individuals is usually benign, with sponta-
neous regression occurring in many cases. In females,
the association with cancer of the cervix suggests a
less benign course, both in women who have lesions
and in the partners of individuals with BP. In the eld-
erly and immunocompromised patients, its evolution
also tends to be more aggressive. 13 Other types of
HPV such as HPV 18, 31-35, 39-42, 48 and 51-54 have
been detected in lesions of BP. 44
V. MALIGNANT MUCUSAL LESIONS
V.1. BOWEN’S DISEASE OF THE GENITALIA
Carcinoma in situ or BD of the genitalia is
associated with high-risk HPVs, especially HPV
16.45 Clinically, it presents as a plaque, usually sin-
gle, without tendency to spontaneous regression
and with potential to progress to SCC. Some
authors consider that mucosal BD corresponds to
erythroplasia of Queyrat (EQ). However, other
researchers believe that they are entities with dif-
ferent histological patterns. The characteristic
lesions of EQ are erythematous, velvety, bright
plaques with or without infiltration, which may
affect the glans, prepuce, urethra, vulva, oral
mucosa, tongue and conjunctiva. EQ progression
to SCC occurs in more than 30% of the cases and is
higher than that observed in relation to BD.
Studies on detection of HPV types in lesions of EQ
are scarce. HPV 16 is the most commonly found
and HPV-EV 8 has also been detected. 46
V.2. VULVAR CANCER
Invasive vulvar cancer is usually preceded by
vulvar intraepithelial neoplasia (VIN) or cervical carci-
noma and often develops from long-course genital
warts. The detection of HPV in vulvar SCC lesions
ranges from 30% to 70%.47 Detection of HPV in vulvar
cancer is much lower than that of cervical carcinoma.
This may be due to the sensitivity of the detection
methods employed or the presence of new HPV types
not yet identified that may be present in the lesions. 13
HPV 16 is the most observed type in vulvar car-
cinomas. HPVs 18, 21, 31, 33 and 34 have also been
detected in these lesions. 
V.3.PENILE CANCER 
Clinically, the lesions are hardened, nodular,
ulcerated or erosive and may present verrucous sur-
face. The detection of HPV in lesions of penile cancer
reaches 40-70% positivity and the most frequent type
is HPV 16. 48
V.4. ANAL CANCER
HPV is detected in approximately 80 to 96% of
anal cancer lesions. The most frequent type is HPV 16.
Other HPVs such as HPVs 18 and 33 are also detected. 47
V.5. CERVICAL CANCER
A large number of lesions of the cervical region
are associated with HPV, from incipient cytologic
abnormalities and dysplasia of varying degrees to cer-
vical cancer. A causal relationship between HPV and
cervical cancer is observed in about 90% to 100% of
the cases. 49 Cervical infection by some types of HPV is
a precursor in the genesis of cervical neoplasia,
although other co-factors contribute to the develop-
ment of neoplasia. 
HPVs 16 and 18 are the two most important car-
cinogenic types and account for about 70% of cervical
carcinomas and 50% of intraepithelial neoplasia grade
3. HPVs 31, 33, 35, 39, 45, 51, 52 and 58 have also
been detected in lesions of cervical cancer. 50
Table 2 shows a summary of the clinical mani-
festations most often associated with each type of HPV.
FIGURE 6: Focal epithelial hyperplasia or Heck's disease in an
indigenous child of the Xingu Indigenous Park
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CONCLUSION
The group of cutaneous HPVs presents a signif-
icant number of different types, with great ubiquity
and many regional and racial differences. The study
and better understanding of HPV are necessary
because these viruses are implicated in skin diseases
that are very common in the practice of dermatologies
as well as they are involved in the etiology of several
cancers. 
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TABLE 2: Major clinical manifestations caused by different types of HPV
HPV type Associated clinical manifestations
1 Deep plantar wart, palmar warts, 
common warts
2 Common warts
3 Flat warts
4 Common warts, endophytic plantar 
warts
5 EV, SCC in EV
6 Anogenital warts, laryngeal papillomas, 
Buschke-Lowenstein tumor, CIN
7 Butcher's wart
8 EV, SCC in EV
9 EV
10 Flat warts
11 Anogenital warts, CIN, laryngeal 
papillomas
12 EV
13 Focal epithelial hyperplasia
14 EV, SCC in EV
15 EV
16 Anogenital warts, CIN, VIN, PIN, 
cervical carcinoma
17 EV, SCC in EV
18 Genital warts, CIN, cervical carcinoma
19 EV
20 EV, SCC in EV
21-25 EV
26 Cutaneous lesions in immunocompromised
patients, rarely genital lesions
27 Common warts
2 Flat and common warts
29 Common warts (rare)
30 Anogenital lesions, laryngeal cancer
31 Anogenital warts, CIN, cervical carcinoma
32 Focal epithelial hyperplasia, laryngeal 
papilloma
33 CIN, VIN, cervical cancer
HPV type Associated clinical manifestations
34 Orogenital warts, cutaneous Bowen's 
disease 
35 Anogenital warts, CIN, cervical cancer
36-38 EV
39 Anogenital warts, CIN, cervical cancer
40 Anogenital warts, CIN, VIN, PIN, 
cutaneous lesions (rare)
41 Flat warts, SCC
42, 43 Anogenital warts
44 Orogenital warts
45 Anogenital warts, CIN, cervical cancer
46 Reclassified as HPV-20b, EV
47 EV, SCC in EV
48 Cutaneous warts (rare), SCC in 
immunocompromised individuals
49 EV, flat warts in immunocompromised 
individuals
50 EV
51 Anogenital warts, CIN, cervical cancer
52, 53 Anogenital warts, CIN, cervical cancer
54 Anogenital warts, Buschke-Lowenstein 
tumor (rare)
55 Orogenital warts, Bowenoid papulosis
56 Anogenital warts, CIN, cervical cancer
57 Orogenital warts, cutaneous warts
58 Anogenital warts, CIN, cervical cancer
59 Orogenital warts
60 Plantar epidermoid cyst
61, 62 VIN
63 Cutaneous warts (rare), plantar warts
64 Orogenital warts, VIN
65 Pigmented flat warts
66-68 Anogenital warts, CIN, cervical cancer
69 CIN
70 Anogenital warts
72 Cervical lesions
Continua
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HPV type Associated clinical manifestations
73 Anogenital warts
75-77 Cutaneous lesions in 
immunocompromised individuals
78 Cutaneous lesions, mucosal lesions (rare)
80 EV, SCC
81 Low-risk mucosal lesions
82 High-risk mucosal lesions, benign lesions
83 Low-risk mucosal lesions
84 Low-risk mucosal lesions
85 High-risk mucous lesions 
86 Low-risk mucosal lesions
87 Low-risk mucosal lesions
HPV type Associated clinical manifestations
88 Cutaneous lesions
89 Low-risk mucosal lesions
90 low-risk mucosal lesions
91 Low-risk mucosal lesions and cutaneous 
lesions
92 EV, pre-malignant cutaneous lesions, SCC
93 EV, pre-malignant cutaneous lesions, SCC
94 Cutaneous lesions, mucosal lesions (rare)
95 Cutaneous lesions 
96 EV, pre-malignant cutaneous lesions, SCC
107 EV, SCC
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